First-in-human evaluation of a novel ultrathin sirolimus-eluting iron bioresorbable scaffold: 3-year outcomes of the IBS-FIM trial.

Run-Lin Gao,Bo Xu,Zhongwei Sun,Changdong Guan,Lei Song,Lijian Gao,Chongjian Li,Jingang Cui,Yin Zhang,Kefei Dou,Jue Chen,Chaowei Mu,Haibo Liu,Ang Li, Zihao Li,Lihua Xie,Yuejin Yang,Shubin Qiao,Yongjian Wu,Gregg W Stone

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology（2023）

引用 1|浏览14

暂无评分

摘要

In this first-in-human experience, an ultrathin IBS was safe and effective for the treatment of de novo non-complex coronary lesions up to 3-year follow-up.

查看译文

关键词

bioresorbable scaffolds, intravascular ultrasound, optical coherence tomography, prior percutaneous intervention, QCA

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要